Public and decision-maker stated preferences for pharmaceutical subsidy decisions in Iran: an application of the discrete choice experiment.

ABSTRACT:

Background

The argument about funding criteria poses challenges for health decision-makers in all countries. This study aimed to investigate the public and decision-maker preferences for pharmaceutical subsidy decisions in Iran.

Methods

A discrete choice experiment (DCE) was used for eliciting the preferences of the public and decision-makers. Four attributes including health gain after treatment, the severity of the disease, prevalence of the disease, and monthly out of pocket and relevant levels were designed in the form of hypothetical scenarios. The analysis was done by using conditional logit analysis.

Results

The results show all of four attributes are important for pharmaceutical subsidy decisions. But a medicine that improves health gain after treatment is mor

SUBMITTER: Afsharmanesh G 

PROVIDER: S-EPMC8422609 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature